Katherine J. Bangen

Associations of metformin-based antidiabetic combinations and Alzheimer’s disease onset: a retrospective EHR cohort study

Abstract Background Type 2 Diabetes (T2D) is an established risk factor for dementia and Alzheimer’s Disease (AD). Previous literature primarily examines the neuroprotective benefits of antidiabetic medications (metformin, SGLT2 inhibitors, and GLP-1 receptor agonists) in isolati...